Senior insider sale
CHIEF MEDICAL OFFICER at ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$1.20M
45K shares
What this filing means
COLLINS HELEN LOUISE plans to sell 45K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $1.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001974158-26-000017
Officer· CHIEF MEDICAL OFFICER
Since Feb 2026
45K
Shares to sell
$1.20M
Approx. market value
45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Options
N/A
8/9/2022
45KTotal acquired45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/9/2022 | Stock Options N/A | 45K | — |
| Total | 45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
45K
Market value
$1.20M
2/17/2026
Total
Units
45K
Value
$1.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/17/2026 | 45K | $1.20M | NASDAQ | Planned |
| Total | 45K | $1.20M | ||